Average Co-Inventor Count = 8.35
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (17 from 4,455 patents)
2. Pharmacia & Upjohn Company (13 from 523 patents)
3. Cystic Fibrosis Foundation Therapeutics, Inc. (3 from 5 patents)
4. Cystic Fibrosis Foundation (3 from 3 patents)
5. Pharmacia & Upjohn (1 from 20 patents)
37 patents:
1. 12202836 - Bicyclic-fused heteroaryl or aryl compounds
2. 11702424 - Bicyclic-fused heteroaryl or aryl compounds
3. 11661419 - Benzimidazole derivative compounds and uses thereof
4. 11559538 - Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors
5. 10946031 - PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol
6. 10906888 - Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
7. 10793579 - Bicyclic-fused heteroaryl or aryl compounds
8. 10766904 - Bicyclic heteroaryl derivatives as CFTR potentiators
9. 10494374 - Pyrrolopyrimidines as CFTR potentiators
10. 10377762 - Bicyclic heteroaryl derivatives as CFTR potentiators
11. 10329302 - Bicyclic-fused heteroaryl or aryl compounds
12. 10316018 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
13. 10301315 - Pyrrolopyrimidines as CFTR potentiators
14. 10208053 - Bicyclic heteroaryl derivatives as CFTR potentiators
15. 10174000 - Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators